ReviewProstaglandins & other lipid mediators2009

Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors.

Xiaoyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.